AMANDA BUTLER: Open Payments
NPI 1659960052 · ELKHORN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 43 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $537 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $207 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $135 |
| Axsome Therapeutics, Inc. | 4 | $75 |
| Vanda Pharmaceuticals Inc. | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Neuronetics, Inc. | 2 | $37 |
| Corium, LLC | 1 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
Products named: VRAYLAR, CAPLYTA, Auvelity, INGREZZA, HETLIOZ, NEUROSTAR TMS THERAPY SYSTEM, ABILIFY ASIMTUFII, Azstarys.
Industry payments across NE — which companies pay providers there.
